| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.3 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.3 | 0.3 |